MANISH DESAI to Drug-Eluting Stents
This is a "connection" page, showing publications MANISH DESAI has written about Drug-Eluting Stents.
Connection Strength
0.084
-
Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial. Lancet. 2025 04 26; 405(10488):1481-1490.
Score: 0.055
-
Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease. Am Heart J. 2015 Oct; 170(4):619-626.e2.
Score: 0.028